These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8146568)

  • 21. Are older breast carcinoma survivors willing to take hormone replacement therapy?
    Ganz PA; Greendale GA; Kahn B; O'Leary JF; Desmond KA
    Cancer; 1999 Sep; 86(5):814-20. PubMed ID: 10463980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Menopause, the down side of medicalization].
    Gendron C
    Can Nurse; 2000 Jan; 96(1):35-40. PubMed ID: 11188678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of the risk-benefit ratio of hormonal replacement therapy for menopause and susceptible elements in maximizing compliance].
    Lopes P; Mensier A
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(7):694-8. PubMed ID: 8991903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hormone replacement therapy in menopause and risk of breast cancer].
    Fournier A; Hill C; Clavel-Chapelon F
    Bull Cancer; 2003 Oct; 90(10):821-31. PubMed ID: 14706912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
    Sammartino A; Cirillo D; Mandato VD; Di Carlo C; Nappi C
    J Endocrinol Invest; 2005; 28(10 Suppl):80-4. PubMed ID: 16550729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of the hematochemical parameters and bone mineral density of women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and surgical menopause treated with estrogen replacement. Part II].
    Savoca S; D'Agosta S; Lombardo G
    Minerva Ginecol; 2007 Jun; 59(3):215-22. PubMed ID: 17576400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Quantitative evaluation of the cardiovascular risk associated with hormone substitution therapy during menopause].
    Scarabin PY; Plu-Bureau G
    Arch Mal Coeur Vaiss; 1993 Feb; 86(2):243-8. PubMed ID: 8363427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The general practitioner's view on hormone replacement therapy during and after menopause].
    Gjelsvik B; Swensen E; Hjortdahl P
    Tidsskr Nor Laegeforen; 2007 May; 127(11):1500-3. PubMed ID: 17551553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The risk of breast, endometrial and ovarian cancer in users of hormonal preparations.
    Bernstein L
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):288-96. PubMed ID: 16611204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
    Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
    Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A hard look at hormone replacement.
    Oates MB; Smith MD; McGhan WF
    Bus Health; 1997 May; 15(5):48, 50-1. PubMed ID: 10167200
    [No Abstract]   [Full Text] [Related]  

  • 35. Menopause and hormone replacement therapy.
    Speroff L
    Clin Geriatr Med; 1993 Feb; 9(1):33-55. PubMed ID: 8443739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postmenopausal hormone therapy: cardiovascular risks.
    Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A computer model to analyze the cost-effectiveness of hormone replacement therapy.
    Zethraeus N; Johannesson M; Jönsson B
    Int J Technol Assess Health Care; 1999; 15(2):352-65. PubMed ID: 10507194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hormone replacement therapy and cardiovascular pathology in menopause].
    Micheli S; Marcucci R; Farsi A; Abbate R
    Ann Ital Med Int; 1998; 13(1):37-46. PubMed ID: 9642841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.